Most importantly, our results provide proof of concept that an immunotherapy against AMH could reverse the major reproductive dysfuntions observed in PCOS, opening up promising avenues for the treatment of women with PCOS. The gene discussed is AMH; the disease is polycystic ovary syndrome.